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An SH3-binding domain within the Nef protein of primate lentiviruses has been reported to be important to viral replication
and infectivity and dispensable for CD4 downregulation, but its precise role remains unclear. This study investigates the
effects of mutations in both the polyproline helix and in the hydrophobic pocket that constitute the SH3-binding domain of
Nef. The data demonstrate that the well-studied mutation of the central prolines is only partially disruptive to viral infectivity
and replication. The central prolines also make a subtle contribution to the efficiency of CD4 downregulation, detectable only
using low levels of Nef expression. Mutation of a conserved arginine in the polyproline helix abrogated more completely
Nef-mediated enhancement of viral infectivity; this mutation also adversely affected CD4 downregulation at low levels of Nef
expression. Only the R77A mutation substantially impaired downregulation of class I MHC. However, mutation of the central
prolines and of R77 yielded proteins that were expressed less efficiently than wild-type Nef. The R77A mutant was expressed
most poorly, compatible with its defective phenotypes in all assays. Mutations of the hydrophobic pocket were minimally
detrimental to both the virologic and the receptor modulatory functions of Nef. Taken together, this analysis suggests that
mutations in the SH3-binding domain do not abrogate fully any Nef-associated phenotype in the absence of detrimental
effects on protein expression. We suggest that mutations in this domain can introduce incomplete effects caused by subtle
impairments to protein expression; these effects may appear selective under certain experimental conditions due to different
sensitivities of the assays to the level of Nef expression. © 1999 Academic Press
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lINTRODUCTION
Nef is a 27-kDa protein encoded by a 39 ORF specific
o primate lentiviruses (Allan et al., 1985). The contribu-
ion of Nef to primate lentiviral pathogenesis is demon-
trated by long-term nonprogressors infected with Nef-
efective HIV-1 (Deacon et al., 1995; Kirchhoff et al., 1995)
s well as studies of Nef-defective SIV in primate models
f AIDS (Kestler et al., 1991). In vitro, Nef is essential for
ptimal viral growth in peripheral blood mononuclear
ells (de Ronde et al., 1992; Miller et al., 1994; Spina et
l., 1994) and in a number of transformed T-cell lines
Chowers et al., 1994; Ryan-Graham and Peden, 1995).
Nef-associated phenotypes seem to fall into three cat-
gories. First, Nef downregulates CD4 and MHC-I from
he cell surface (Guy et al., 1987; Garcia and Miller 1991;
chwartz et al., 1996). Second, Nef enhances viral infec-
ivity via a modification of the virion at the time of pro-
uction in a manner which aids the accumulation of viral
NA in newly infected cells (Aiken and Trono 1995;
howers et al., 1995; Miller et al., 1995; Schwartz et al.,
995; Pandori et al., 1996). Third, Nef alters T-cell signal-
ng pathways (Luria et al., 1991; Skowronski et al., 1993;
1 To whom reprint requests should be addressed. Fax: (619) 552-
e445. E-mail: jguatelli@ucsd.edu.
55aur et al., 1994; Greenway et al., 1995; Graziani et al.,
996).
Mutational analyses have identified domains within
ef that are specifically involved in one phenotype but
ot another (Goldsmith et al., 1995; Saksela et al., 1995;
iskerchen and Cheng-Mayer, 1996; Iafrate et al., 1997).
ne such domain is a proline-rich domain that mediates
nteraction with cellular proteins via their Src homology-3
SH3) regions. In vitro, the two central prolines of this
omain in Nef are required for optimal viral replication
nd infectivity but not for CD4 downregulation (Goldsmith
t al., 1995; Saksela et al., 1995; Wiskerchen and Cheng-
ayer, 1996). This region within Nef preferentially binds
he SH3-containing proteins Hck and Lyn (Saksela et al.,
995). The polyproline helix within Nef also is required
or association with a PAK-like serine/threonine kinase
ctivity (Sawai et al.,1994; Lang et al., 1997) although
AK-family kinases are not known to contain SH3 do-
ains. All of these findings suggest that Nef may interact
ith kinases of cellular signalling pathways. However,
he role of the central proline residues of the SH3-bind-
ng domain in vivo is controversial. Studies using HIV/
CIDhu mouse and SIV/macaque models have provided
vidence both for and against the necessity of these
esidues for normal disease progression and high viral
oads (Lang et al., 1997; Aldrovandi et al., 1998; Kawano
t al., 1998; Khan et al., 1998).
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56 CRAIG ET AL.In vivo, Nef may confer a growth advantage to virus by
ownregulating class I MHC and thereby enabling in-
ected cells to avoid CTL killing (Schwartz et al., 1996;
ollins et al., 1998). A recent report indicates that the two
entral prolines of the polyproline helix of the SH3-bind-
ng domain are required for Nef-mediated downregula-
ion of MHC-1 (Greenberg et al., 1998). This study in-
luded another mutation of the SH3-binding domain,
86A; this aspartate is outside the polyproline helix but
articipates in the Nef-SH3 binding interaction (Lee et
l., 1996). Both SH3-binding domain mutants were un-
ble to block CD69 upregulation after CD3-mediated
ignalling, a property of wild-type Nef. Although the pro-
ine mutation rendered Nef dramatically defective in
HC-1 downregulation, the D86A mutation was only
artially defective. These observations indicate that ele-
ents of the Nef SH3-binding surface that are well de-
ined structurally may have different functional attributes
n biological assays.
Analysis of the binding affinities of a peptide contain-
ng the polyproline helix of Nef with various SH3 domains
ndicated that the helix alone does not bind to SH3 with
he same affinity as whole Nef (Lee et al., 1995). This
bservation suggested that additional interactions must
ccur between Nef and SH3 outside of the Nef polypro-
ine helix. Indeed, x-ray crystallographic and NMR spec-
roscopic studies indicate that the so-called RT loop of
H3 interacts with a hydrophobic pocket in the well-
olded core of Nef (Grzesiek et al., 1996; Lee et al., 1996).
his region of the SH3 domain of Hck contains an iso-
eucine residue that confers high binding affinity for Nef
Lee et al., 1995). This isoleucine packs against the
ydrophobic side chains of Nef residues L87, F90, W113,
nd I114 in the crystal structure of Nef–SH3 complexes
Lee et al., 1996)
Previous studies of the SH3-binding domain of Nef
ave focused primarily on mutations of the central pro-
ines within the polyproline helix, whereas the involve-
ent of amino acids within the hydrophobic pocket pre-
FIG. 1. Linear map of HIV-1 Nef protein emphasizing the SH3-binding
iscontinuous linearly and consists of a polyproline helix (cross-hatche
ther major features of HIV-1 Nef protein, the protease-cleavage site and
he protease cleavage site; cross-hatching: the polyproline helix of theicted to interact with the RT loop of SH3 domains has sot been investigated. This report analyzes the effects of
utations both within the polyproline helix and within the
ydrophobic pocket of Nef. In contrast to previous stud-
es, the present analysis indicates that mutations in the
ef SH3-binding domain, although detrimental, do not
brogate fully any in vitro function of Nef in the absence
f negative effects on protein expression. This nonoblig-
tory nature of the SH3-binding domain in vitro is in
otential agreement with its reported dispensability for
athogenesis in vivo (Lang et al., 1997; Aldrovandi et al.,
998; Kawano et al., 1998). Also in contrast to previous
tudies, the present analysis reveals subtle defects in
he efficiency of CD4 downregulation caused by muta-
ions within the SH3-binding domain that are revealed by
ow-dose Nef expression.
RESULTS
utations within the polyproline helix or the
ydrophobic pocket of the Nef SH3-binding domain
ause variable, incomplete defects in viral replication
NMR spectroscopic and x-ray crystallographic data
ndicate that when Nef and SH3-containing tyrosine ki-
ases are in complex, interactions occur not only involv-
ng residues of the Nef polyproline helix but also involv-
ng residues of a hydrophobic pocket in the well-folded
ef core (Grzesiek et al., 1996; Lee et al., 1996). Each of
hree amino acids that line this hydrophobic pocket was
utated to encode an alanine (Fig. 1). These mutant nef
lleles were designated F90A, W113A, and I114A. In
ddition, these structural studies indicate that a con-
erved arginine residue within the polyproline helix par-
icipates in multiple electrostatic and hydrogen bonding
nteractions between Nef and SH3 (Fig. 1). This arginine
t position 77 also was mutated to encode an alanine;
his mutant nef allele was designated R77A. Furthermore
he previously well-examined mutant nef allele P72/75A
PA-1), which contains alanine substitutions of the cen-
ral prolines of the polyproline helix, was obtained (Sak-
e and the residues mutated in this study. The SH3-binding surface is
hydrophobic pocket formed by two alpha helices. The location of two
lvent-exposed, C-terminal loop, are shown for reference. Light stipling:
ding domain; open boxes: alpha helices; heavy stipling: beta-strands.surfac
d) and a
the soela et al., 1995). To determine the effect of these muta-
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57SH3-BINDING DOMAIN MUTANTS OF HIV-1 Nefions on the ability of the virus to replicate in culture, viral
roduction from human peripheral blood mononuclear
ells (PBMCs) was measured. PBMCs stimulated with
L-2 and PHA were infected with equivalent amounts of
ach virus as determined by p24 antigen content, and
iral production in the cultures was measured over time
Fig. 2). Consistent with previous reports, mutation of the
wo central prolines in the polyproline helix caused a
efect in the rate of viral replication. However, this defect
as not as great as that caused by complete disruption
f the nef gene (Dnef). The other mutant of the polypro-
ine helix analyzed, R77A, also introduced a substantial
ut incomplete defect in viral replication when compared
ith Dnef. Mutations of the hydrophobic pocket residues
90, W113, and I114 caused more modest defects in viral
rowth rate (Fig. 2).
utations within the polyproline helix or the
ydrophobic pocket of the Nef SH3-binding domain
ause variable defects in the infectivity
f cell-free virions
The infectivities of viruses containing the mutant nef
lleles were assessed using a syncytium-formation as-
ay (Fig. 3A). Of the missense mutations analyzed, ala-
ine substitution of the arginine at position 77 was the
ost detrimental to viral infectivity. Though the growth
ates of the R77A and P72/75A mutants were similar in
ultures of primary lymphoblasts (Fig. 2), mutation of the
FIG. 2. Viral growth in PBMCs. PBMC cells (1 3 106) were stimulate
roduced from CEM cells (an amount equivalent 1 [mult] 105 pg of p24
he culture supernatants were collected and the cultures were split at
LISA is plotted as a function of time. Error bars are the standard error o
sing independently derived cells and viral stocks.entral prolines of the polyproline helix did not effect viral dnfectivity to the same extent as the R77A mutation (Fig.
A). Over the course of three independent experiments,
he P72/75A mutation was consistently less detrimental
o infectivity than R77A or deletion of the nef gene and in
eneral was characterized by an intermediate pheno-
ype. To verify that the mutations introduced in nef did not
ntroduce cis-acting defects, viruses were produced from
EM cells that contain a wild-type nef regulated by the
IV-1 LTR, [CLN cell line (Pandori et al., 1996)] and
nalyzed for infectivity using the syncytium-formation as-
ay. All infectivity defects observed upon mutation of the
H3-binding domain were complemented by Nef pro-
ided in trans, indicating that mutations in the sequence
ncoding the hydrophobic pocket (which overlaps the U3
egion of the LTR) did not introduce cis-acting defects
data not shown). Because certain nef mutants have
een characterized by discordant phenotypes when pro-
uced from different cell types, in particular, 293 cells
ompared with T cells, virus was produced from 293
ells and titered as described above (Fig. 3B). These
ata revealed the same general hierarchy among the
utants; only the R77A mutant was characterized by a
omplete defect.
utations within the polyproline helix or hydrophobic
ocket have small but detectable effects
n Nef-mediated CD4 downregulation
Mutant Nef proteins were tested for their ability to
IL-2 (50 U/ml) and PHA (3 mg/ml) 3 days before infection with viruses
n). NL4–3 indicates the wild-type virus. Every 3 or 4 days, samples of
atio. The amount of p24 antigen in the supernatants as measured by
cate infections. The data shown are representative of two experimentsd with
antige
a 1:4 r
f dupliownregulate CD4. 293 cells were transiently trans-
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58 CRAIG ET AL.ected with a CD4-expression plasmid and varying
mounts of Nef-expression plasmids and were assayed
y FACS for surface levels of CD4 (Fig. 4A). To detect
ubtle defects, a dose-response curve was generated
sing amounts of Nef-expression plasmids ranging from
to 2 mg. Mutations of the SH3-binding domain had no
pparent effect on CD4 downregulation at the 2-mg plas-
id dose. However, at plasmid doses of #0.5 mg, subtle
efects in several of the SH3-binding domain mutants,
FIG. 3. Analysis of Nef-mediated enhancement of infectivity of vi-
uses produced from CEM cells (A) and from 293 cells (B). The relative
nfectivities of cell-free virions produced from the indicated genomes
ere determined by using an infectious center assay in which CD4-
ositive HeLa cells were used as targets. The infectivities of the mutant
irions were determined as described and are expressed relative to
ild type. Error bars are the standard error of duplicate titrations of the
ame viral stock. For each producer cell type, the data shown are
epresentative of three experiments using independently derived viral
tocks.ncluding P72/75A and R77A, were revealed. Neverthe- ress, mutations in the SH3-binding domain were in gen-
ral much less deleterious to Nef-mediated CD4 down-
egulation than they were to the virologic function of Nef.
utations in the polyproline helix of the SH3-binding
omain affect Nef expression
The discordance between the effect of mutations
ithin the polyproline helix (P72/75A and R77A) on the
irologic function of Nef and on CD4 downregulation has
everal potential explanations. As has been proposed
reviously, the polyproline helix of the SH3-binding do-
ain may participate in an interaction that is specific to
he process of viral replication. Alternatively, the virologic
nd CD4-modulatory functions of Nef may have different
ose-response ranges that allow slight differences in
rotein expression to manifest as apparently selective
ffects. To determine the relative levels of Nef expres-
ion by the mutant alleles, Western blot analysis was
erformed on the cells transfected with the 0.25-mg nef-
lasmid dose described in Fig. 4A. Cells transfected with
utant alleles P72/75A and R77A had reduced Nef ex-
ression as compared with those transfected with the
ild-type nef allele (Fig. 4B). Concordant with its more
efective phenotype in enhancement of infectivity, the
77A protein appeared less well expressed than the
72/75A protein. These findings suggest that these mu-
ations in the polyproline helix rendered Nef less stable.
ith the exception of R77A, mutations of the
H3-binding domain have minimal effects
n MHC-I downregulation
To assay the ability of mutant Nef alleles to downregu-
ate class I MHC, 293 cells were transfected with Nef-
xpressing plasmids, and the expression of endogenous
LA-A2 was measured using flow cytometry. To achieve
ufficient levels of Nef expression to observe this effect,
roviral constructs were required for Nef expression
data not shown). Transfection of wild-type NL4–3 provi-
us significantly reduced MHC-I surface levels as de-
ected by a decrease in the mean PE-fluorescence com-
ared with that of the control in which no proviral DNA
as included (Fig. 5A). Use of a nef-negative proviral
onstruct as a control allowed observation of the fraction
f MHC-I downregulation that was due to Nef and not to
ther viral proteins such as Vpu (Kerkau et al., 1997). In
ontrast to recently published data (Greenberg et al.,
998), mutation of the two central prolines of the polypro-
ine helix had only a small effect on the ability of Nef to
ownregulate MHC-I. Mutations F90A, W113A, and I114A
lso had little or no effect on this function of the protein.
n contrast, the mutation R77A abrogated MHC-I down-
egulation substantially. These data indicate that only
77A, which encodes a protein that is inefficiently ex-
ressed, was markedly defective in its ability to down-egulate MHC-1. Western blot analysis performed on
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59SH3-BINDING DOMAIN MUTANTS OF HIV-1 Nefells assayed for MHC class I surface expression con-
irmed the relative expression levels of these mutant
roteins as was observed during the CD4 down regula-
ion assays (compare Figs. 4B and 5B).
DISCUSSION
The presence of an SH3-binding domain within Nef is
trongly suggestive that Nef may interact with an SH3-
ontaining protein, perhaps a cellular molecule involved
n signal transduction. Although initial data suggested an
mportant role of such an interaction in optimal viral
rowth and infectivity, the role of this domain in Nef-
ssociated pathogenesis is controversial. Thus far, the
FIG. 4. Analysis of CD4 downregulation by mutant Nef alleles. (A) Dos
oint is the result of an independent transfection. 293 cells were trans
g), and the indicated amounts of the Nef-expression plasmids. All tran
lasmid vector used to express the nef alleles. Cells were stained with
E-fluorescence (CD4 surface levels) of the GFP-positive populations i
re representative of two independent experiments. (B) Western blot a
.25 mg of each Nef expression vector were lysed, separated electro
CI-neo is the empty expression vector; pCI-NL contains the wild-typeajority of published mutational analyses of this domain tave focused on the central prolines of the polyproline
elix (Goldsmith et al., 1995; Saksela et al., 1995;
iskerchen and Cheng-Mayer, 1996; Iafrate et al., 1997;
reenberg et al., 1998). In our initial experiments, the
roline mutations did not introduce consistent defects in
iral infectivity. The current investigation of other muta-
ions of the SH3-binding domain of Nef was intended to
larify the role of this domain in Nef-associated pheno-
ypes.
We have concurrently analyzed five mutations in the
H3-binding domain of Nef: mutation of the two central
rolines of the polyproline helix, mutation of a universally
onserved arginine within the polyproline helix, and
onse FACS analysis of Nef-mediated CD4 downregulation. Each datum
ith a CD4-expression plasmid (1 mg), a GFP-expression plasmid (0.5
ns were standardized to contain 3.5 mg of total DNA using pCIneo, the
jugated anti-CD4 antibody and analyzed by flow cytometry. The mean
ed versus the amount of Nef expression plasmid. The results shown
of Nef expression. Cells analyzed in A (1 3 105) and transfected with
ically, and analyzed by Western blot using a Nef-specific antiserum.
nce.e-resp
fected w
sfectio
PE-con
s graph
nalysis
phorethree mutations of residues that line a hydrophobic
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60 CRAIG ET AL.ocket which further defines the SH3-binding domain.
lthough all mutants reduced the rate of viral replication,
he two polyproline helix mutations, P72/75A and R77A,
ere more detrimental than mutations in the hydropho-
ic pocket. These effects correlated with the reduced
nfectivities of these viruses as measured using an in-
ectious center assay. However, only the R77A mutation
educed viral infectivity to the level of nef-negative virus.
hese data regarding the incomplete defect introduced
y mutation of the central prolines are consistent with
he findings that mutation of the prolines in the polypro-
ine helix neither interrupts pathogenesis caused by SIV
n rhesus macaques (Lang et al., 1997) nor blocks CD4
epletion in the SCIDhu murine model (Aldrovandi et al.,
998).
Previous reports described a genetic separation of
FIG. 5. Analysis of MHC class-I downregulation by mutant Nef all
roduction. 293 cells (5 3 105) were transfected with 8 mg of provi
FP-expression plasmid (0.5 mg). Two days after transfection, cells we
y flow cytometry. The mean PE-fluorescence (MHC-I surface level) of th
ere analyzed by ELISA for p24 content at the time of cell harvest to a
re plotted as asterisks using a third axis on the right. The data shown
xperiments. (B) Western blot analysis of Nef expression. Cells analyze
y Western blot for Nef.D4 downregulation and infectivity phenotypes by exam- dning mutations of the central prolines of the polyproline
elix (Goldsmith et al., 1995; Saksela et al., 1995;
iskerchen and Cheng-Mayer, 1996). Here, we have
emonstrated that this finding is consistent with the
ffects of another mutation in the same region of the
rotein, R77A. These findings have led to the proposal
hat the SH3-binding domain plays a role in a function of
ef that enhances viral infectivity but is independent of
D4 downregulation. Our data indicate, however, that
utations in this region introduce defects in protein
xpression. This effect was most dramatic in the case of
77A but was detectable for the central proline muta-
ions as well. Notably, the use of low doses of Nef
xpression vectors revealed that the two polyproline
elix mutations (P72/75A and R77A) introduced a slight
efect in CD4 downregulation. Thus, although CD4
) FACS analysis of MHC-I surface levels and measurement of p24
tors expressing each of the mutant nef alleles as indicated and a
ed with a PE-conjugated anti-class I MHC-A2 antibody and analyzed
positive cells is plotted for each mutant nef allele. Culture supernatants
the relative efficiencies of proviral gene expression. These quantities
wnregulation of class I MHC are representative of three independent
) (1 [mult] 105) were lysed, separated electrophoretically, and analyzedeles. (A
ral vec
re stain
e GFP-
ssess
on do
d in (Aownregulation may have appeared genetically separa-
b
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61SH3-BINDING DOMAIN MUTANTS OF HIV-1 Nefle from other Nef-associated phenotypes, detrimental
ffects on CD4 downregulation introduced by mutations
n this region may not have been revealed at the expres-
ion levels analyzed in some previous studies.
The observation that mutations in the polyproline helix
ay affect protein expression and downregulation of
D4 has some precedent. Pulse–chase studies have
ndicated that the stability of R77A is only 35% of that of
ild type, whereas that of the central-proline mutant was
5% (Iafrate et al., 1997). Dose-response studies similar
o those herein indicated that the relative activities in
ownregulation of CD4 was 50% of wild type in the case
f the central proline mutant and 40% in the case of the
77A mutant (Iafrate et al., 1997). Together with the data
erein, these observations support the conclusion that
utations in the polyproline helix may affect protein
tability and expression. A variety of interactions be-
ween the polyproline helix and the remainder of the
ell-folded Nef core has been described (Lee et al.,
996). These include hydrogen bonds between Q73 and
he backbone of an a helix in the Nef core, between R77
nd Nef residues 118 and 121, and between L76 and
119. Thus it is conceivable that mutations within the
olyproline helix might destabilize the protein and cause
t least partial loss of function.
Recently, mutation of the two central prolines has been
eported to abrogate Nef-mediated MHC-I downregula-
ion (Greenberg et al., 1998). In the current study, how-
ver, this mutation had only modest effects upon MHC-I
ownregulation. In contrast, the R77A mutation intro-
uced a more complete defect in this phenotype. How-
ver, the larger impact on Nef expression caused by the
77A mutation as compared with that caused by the
72/75A mutation is likely to account for the observed
ffects upon MHC-I downregulation.
Mutations of residues that line the hydrophobic pocket
f the SH3-binding domain were less detrimental to all
ef phenotypes than mutations of the polyproline helix.
lthough defined structurally and biochemically as part
f the high-affinity SH3-binding surface, these residues
o not appear critical for Nef function in the in vitro
ssays used herein. However, it remains conceivable
hat alanine substitutions of these residues are permis-
ive for SH3-binding, and as a consequence these mu-
ations may have little phenotypic impact. Nevertheless,
e feel this is not likely, because the interaction of the
T-loop of SH3 appears to involve a hydrophobic inter-
ction in which the isoleucine 96 side chain of the SH3
omain, required for high-affinity binding to Nef, is
acked against the side chains of Nef residues F90,
113, and I114 (Lee et al., 1996).
Collectively, analysis of these SH3-binding domain
utants suggest that Nef-associated phenotypes may be
ifferentially dependent upon levels of protein expres-
ion. Specifically, assays of viral infectivity, replication,
nd MHC-1 downregulation may be the most sensitive, fhereas CD4 downregulation appears to be relatively
nsensitive to partial defects in expression. These poten-
ial relationships are best exemplified by the R77A mu-
ant, which is inefficiently expressed and retains signifi-
ant activity only in CD4 downregulation. Indeed, the
efects of the SH3-binding domain mutants in pheno-
ypic assays appear, in most cases, directly correlated
ith their defects in protein expression as measured by
estern blot at steady state. Together with the lack of a
niform effect of mutations along the SH3-binding sur-
ace including the minimal defects introduced by muta-
ions in the binding pocket for the RT loop of SH3, these
ata suggest that biological assays that reflect SH3-
ediated Nef function remain to be defined. The subtle
nstability introduced by mutations of this region of Nef
ay render the identification of such a function difficult.
MATERIALS AND METHODS
xpression vectors and proviral constructs
The CMV-driven CD4 expression vector pCMX-CD4
as provided by Didier Trono (Aiken et al., 1994). The nef
ene was subcloned from the HIV-1 proviral clone
NL4–3 (Adachi et al., 1986) by PCR into the CMV-driven
xpression vector pCIneo (Promega), utilizing the unique
coRI and SalI sites within the multiple cloning site of
CIneo; this construct was designated pCINL. Mutations
ere introduced into pCINL using an overlapping PCR
trategy and mutant primers. For the construction of
roviral plasmids, mutant nef alleles were subcloned
rom the pCIneo-based expression vectors directly into
NL4–3 using the PmlI and XhoI sites within the nef
equence. The sequences of all constructs were verified
y nucleotide sequence analysis. The nef negative con-
rol, pDnef, contained a deletion of 185 nucleotides in the
ef gene resulting in a frameshift and a premature stop
odon as described previously (Spina et al., 1994).
iral production
Proviral plasmids were used to transfect the CD4-
ositive T-cell line CEM as described previously (Chow-
rs et al., 1994). Cultures were split at a 1:4 ratio every 3
ays. Supernatants were collected 9–15 days posttrans-
ection. 293 cells also were utilized for production of viral
tocks. Proviral plasmids were introduced into these
ells via calcium phosphate transient transfection using
he CellPhect Kit (Pharmacia) according to the manufac-
urer’s instructions. Supernatants were harvested 48 h
fter transfection. All supernatants were filtered through
0.45m filter, pelleted at 16,000 g, and their p24 contents
ere measured by ELISA (Coulter).
etermination of viral growth rate
Peripheral blood mononuclear cells were isolated
rom HIV-1 seronegative blood donors by centrifugation
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62 CRAIG ET AL.n Ficoll–Hypaque density gradients. Three days before
nfection, the cells were treated with PHA (3 mg/ml) and
L-2 (25 U/ml) to generate cultures of primary lympho-
lasts. After 15 h of incubation with an amount of virus
ontaining 100 ng of HIV-1 p24 antigen, cells were
ashed three times in fresh medium and then assayed
or p24 content. Cultures were harvested at the indicated
imes postinfection and the concentration of p24 antigen
as determined by ELISA (Coulter).
etermination of viral infectivity
Particle infectivity was determined as described pre-
iously (Pandori et al., 1996). HeLa cells expressing hu-
an CD4 (HT4–6C cells), were plated in 24-well plates at
density of 2.7 3 104 cells per well. Twelve to 24 h after
lating, cells were infected with serial dilutions of each
iral stock in the presence of 0.5 mg/ml Polybrene and 8
g/ml DEAE dextran. Three days later, the cultures were
ixed in methanol and stained with crystal violet. Syncytia
ere counted and the amount of virus, as determined by
uantitation of p24 antigen using an ELISA (Coulter),
equired to induce formation of a single syncytium was
alculated. The infectivities of the mutants were ex-
ressed relative to that of wild-type virus.
ransient transfections for analysis of CD4
nd MHC-I downregulation
293 cells (5 3 105) were plated in each well of six-well
lates. Twelve to 20 h after plating, cells were trans-
ected with the DNAs of interest using the reagents of the
harmacia CellPhect Transfection Kit according to the
anufacturer’s instructions. The amounts of total DNA in
ach transfection were standardized as necessary by
he addition of pCIneo parental plasmid. A CMV-driven
fp-expression vector, phGFP-S65T (Clontech) was in-
luded in each transfection to allow identification of
ransfected cells.
ell-surface staining and FACS analysis
Cells were removed from plates with 1 mM EDTA, 13
BS 36–48 h after transfection. Cells were washed twice
n a solution of 13 PBS, 1% azide, and 2% fetal calf
erum, then stained for 30 min at 40°C with phyco-
rythrin (PE)-conjugated monoclonal antibody Leu3A to
etect CD4 (Becton Dickinson) or with a PE-conjugated
onoclonal antibody with specificity for class I MHC
ubtype A2, which was generously provided by Dr. David
amarini. After staining, cells were washed twice, then
ixed in 1% paraformaldehyde. Flow cytometric analysis
as performed on an Ortho Cytofluorograf 50H or a
oulter Elite cytometer. Cells were gated based on for-
ard-scatter and side-scatter characteristics. Cells were
ated further based on GFP positivity to identify the
ubset of successfully transfected cells for analysis.estern blot analyses
Transfected 293 cells (1.25 3 104) were washed and
ysed in SDS–PAGE loading buffer containing b-mercap-
oethanol. Proteins were separated by SDS–PAGE, trans-
erred by electroblotting, and probed using a polyclonal
heep antibody specific for NefHIV-1. Specific bands were
isualized using a horseradish peroxidase conjugated
econdary antibody and the ECL detection system (Am-
rsham).
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